BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16564522)

  • 1. Reversal of MDR1 gene-dependent multidrug resistance using low concentration of endonuclease-prepared small interference RNA.
    Li L; Xu J; Min T; Huang W
    Eur J Pharmacol; 2006 Apr; 536(1-2):93-7. PubMed ID: 16564522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein.
    Pichler A; Zelcer N; Prior JL; Kuil AJ; Piwnica-Worms D
    Clin Cancer Res; 2005 Jun; 11(12):4487-94. PubMed ID: 15958634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
    Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
    Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
    Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of MDR1 gene expression in multidrug resistant MCF7 cells by low concentrations of small interfering RNAs.
    Stierlé V; Laigle A; Jollès B
    Biochem Pharmacol; 2005 Nov; 70(10):1424-30. PubMed ID: 16214115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
    Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z
    Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
    Tsang WP; Kwok TT
    Oncogene; 2007 Jul; 26(33):4877-81. PubMed ID: 17297456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference.
    Stege A; Priebsch A; Nieth C; Lage H
    Cancer Gene Ther; 2004 Nov; 11(11):699-706. PubMed ID: 15375376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
    Dönmez Y; Gündüz U
    Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
    Kaszubiak A; Holm PS; Lage H
    Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells.
    Peng Z; Xiao Z; Wang Y; Liu P; Cai Y; Lu S; Feng W; Han ZC
    Cancer Gene Ther; 2004 Nov; 11(11):707-12. PubMed ID: 15375375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.
    Gao P; Zhou GY; Guo LL; Zhang QH; Zhen JH; Fang AJ; Lin XY
    Cancer Lett; 2007 Oct; 256(1):81-9. PubMed ID: 17637500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells.
    Zhang H; Wang J; Cai K; Jiang L; Zhou D; Yang C; Chen J; Chen D; Dou J
    J Cancer Res Ther; 2012; 8(2):226-31. PubMed ID: 22842366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
    Xu D; Lu Q; Hu X
    Cancer Lett; 2006 Nov; 243(2):274-80. PubMed ID: 16406853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming multidrug resistance by RNA interference.
    Stege A; Krühn A; Lage H
    Methods Mol Biol; 2010; 596():447-65. PubMed ID: 19949936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the reversal of multidrug resistance by MDR1 ribonucleic acid interference in a human colon cancer model using a Renilla luciferase reporter gene and coelenterazine.
    Jeon YH; Bae SA; Lee YJ; Lee YL; Lee SW; Yoon GS; Ahn BC; Ha JH; Lee J
    Mol Imaging; 2010 Dec; 9(6):343-50. PubMed ID: 21084030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulatory effect of small interfering RNA targeting multidrug resistant protein 1 on chemosensitivity of human multiforme glioblastoma cell line BT325].
    Zhao P; Zhang YZ; Sun MZ
    Ai Zheng; 2005 Dec; 24(12):1436-41. PubMed ID: 16351788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.
    Hu XF; Slater A; Rischin D; Kantharidis P; Parkin JD; Zalcberg J
    Br J Cancer; 1999 Feb; 79(5-6):831-7. PubMed ID: 10070877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.